2023 - 2025
On this page
Skip the menu of subheadings on this page.ACNFP advice documents published between 2023 - 2025. Please click on the year to access each page.
2025
Cannabidiol (CBD) isolate - RP340
Cannabidiol (CBD) isolate - RP793
Krill Protein Hydrolysate - RP1290
Dried Miracle Berry (Synsepalumdulcificum) - RP1351
Cannabidiol (CBD) isolate - RP354
Cannabidiol (CBD) isolate - RP11
UV-treated A.Bisphorus Mushroom Powder within creased vitamin D2 - RP1550
Pasteurised Akkermansia muciniphila - RP1468
2024
6’-sialyllactose (6’-SL) sodium salt - RP1478
3’-sialyllactose (3’-SL) sodium salt - RP1477
2’-fucosyllactose (2’-FL) - RP1476
Genetically modified GHB811 cotton - RP1232
Genetically modified GMB151 soybean - RP1123
Genetically modified DP4114xMON810xMIR604xNK603 Maize and sub-combinations - RP1506
Genetically modified 73496 oilseed rape - RP1372
Genetically modified soybean A5547-127 - Renewal RP188
Genetically modified soybean 40-3-2 - Renewal RP212
Genetically modified GHB614 cotton - Renewal RP608
Genetically modified MIR162 maize - Renewal RP652
Isomalto-oligosaccharides - RP1033
Calcidiol (25-hydroxycholecalciferol monohydrate) - RP35
Synthetic cannabidiol (CBD) - RP07
Cannabidiol (CBD) isolate - RP350
Schizochytrium sp.oil rich in DHA and EPA - RP1411
3-fucosyllactose (3-FL) - RP1202
2023
Lacto-N-fucopentaose I (LNFP-I) and 2'-fucosyllactose (2'-FL) - RP549